Wednesday, 13 November 2019

Generics News

  • Aurobindo to acquire Actavis generics unit in EU

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 20 Jan, 2014

    Mumbai: India-based Aurobindo Pharma intends to acquire Actavis' generics commercial operations in seven markets in Western Europe. The transaction is conditional on certain antitrust appro...Read more

  • Ranbaxy sues Actavis to stop acne generic sale

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Nov, 2013

    Singapore: Dublin headquartered generic drugmaker Actavis has now been caught in a legal tangle after Indian drug major Ranbaxy Laboratories filed a legal case against the company. Ranbaxy...Read more

  • IPAB revokes patent for GSK's anti-cancer drug

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

    New Delhi: In yet another blow to multinational companies operating in India, the Intellectual Property Appellate Board (IPAB) has revoked the patent for UK drug maker GlaxoSmithKline's GSK...Read more

  • TWi appoints new CEO to boost US market

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Mar, 2015

    Singapore: Taiwan based TWi Pharmaceuticals has appointed Ms Tina Guilder as President and CEO and Ms Eva Ho as CFO to step up the US operation. TWi Pharmaceuticals announced that Ms Guild...Read more

  • German firm buys $200 mn stake in Indian generic company

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 28 Nov, 2013

    Singapore: Gland Pharma, a leading Indian pure-play generic injectable pharmaceutical products company, has signed an agreement under which KKR, a global investment firm, will acquire a min...Read more

  • Biocon: A nesting ground for biotech spinoffs

    Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 16 May, 2014

    It has added one more feather to its cap by being the nesting ground to churn out new start-ups. It is an informal incubation lab for new spinoffs. Biocon, without any hesitance, is the mo...Read more

  • FAPA: Indian pharma to fatten in biosimilars era

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 14 Aug, 2014

    Singapore: The Federation of Asian Pharmaceuticals Association (FAPA) said that the upcoming patent cliff will be advantageous for the Indian drug makers as biosimilars are all set to make ...Read more

  • Celltrion files an FDA application for biosimilar

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 14 Aug, 2014

    Singapore: With biosimilars promising an exponential growth, South Korea's Celltrion has filed an FDA application for Remisma, a biosilmilar of Johnson & Johnson's (J&J) blockbuster...Read more

  • Wockhardt's third Indian plant faces export ban

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 23 Oct, 2013

    Singapore: Britain's drug regulator, the UK Medicines and Healthcare Products Regulatory Agency has revoked the quality compliance certificate provided to Wockhardt's third unit in India. ...Read more

  • Cipla appoints Subhanu Saxena as CEO

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 23 Nov, 2012

    Mumbai: Indian generic pharmaceuticals company Cipla appointed Mr Subhanu Saxena as its chief executive officer. Mr Saxena comes to Cipla with experience of over 25 years, having worked wit...Read more

  • Cipla divests its stake from a Chinese firm

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 11 Dec, 2014

    Singapore: Indian pharma major, Cipla recently announced that the company's wholly owned subsidiary Meditab holdings entered into a definitive agreement to sell its entire 48.22 per cent st...Read more

  • Lupin, LG to launch an anti-diabetes drug

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 12 Aug, 2014

    Singapore: Indian drug major Lupin has inked a marketing pact with South Korea's LG Life Sciences to launch its anti-diabetes drug in India. As per the strategic distribution pact inked b...Read more

  • GSK to appoint RBS exec as new chairman

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 11 Aug, 2014

    Singapore: British drug maker GlaxoSmithKline is in advanced talks to recruit Sir Philip Hampton, chairman of Royal Bank of Scotland, as the next chairman. According to Sky News report, Sir...Read more

  • Cipla's HIV drug gets tentative nod from FDA

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 27 Feb, 2014

    Singapore: India based generic drug maker Cipla has recieved FDA tentative approval for a generic formulation of emtricitabine and tenofovir disoproxil fumarate tablets, 200 mg/300 mg. The...Read more

  • Dr. Reddy's Azacitidine for injection gets FDA nod

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    Singapore: The US FDA has granted approval for the launch of Dr. Reddy's Laboratories's cancer drug Azacitidine for injection. This generic version of Vidaza is used in the treatment of mye...Read more

  • Aurobindo aims for $2 bn revenues by FY15

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2014

    Singapore: India-based Aurobindo Pharma eyes on globalization and innovation to achieve a turnover of $2 billion in the current fiscal year. With 45 files under review with the USFDA, the ...Read more

  • Alvogen acquires Korea's Dream Pharma

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 08 Aug, 2014

    Singapore: The birth of one of the largest generic pharmaceutical companies in South Korea just came about when Alvogen decided to acquire Korea's Dream Pharma. The deal, closed in cash, in...Read more

  • Aurobindo gets FDA nod for anti-depression generic

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2012

    Singapore: India's Aurobindo Pharma received final approval from the US FDA to manufacture and market Escitalopram Oxalate tablets 5mg, 10mg and 20mg (ANDA 090432), which was earlier tentat...Read more